Clinical Trial: Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease

Brief Summary: Cushing's disease is a rare serious condition that is caused by an adrenocorticotropic hormone (ACTH) secreting pituitary adenoma. This study will assess the long-term safety and efficacy of pasireotide in patients with Cushing's disease.